Biotechnology & Pharmaceutical
Strategic partners for innovation in biotechnology and pharmaceuticals.
As the life sciences industry experiences unprecedented innovation and rapid expansion, many top biotechnology, medical device, and pharmaceutical companies look for strategic partners that offer knowledge regarding the research, development, and commercialization of life sciences products and services, and related intellectual property protection.
Perkins Coie is privileged to have clients that include a diverse range of companies both public and private, focusing on therapeutics (including biologics, biosimilars, and small molecules), prophylactics, diagnostics, and related services, in the life sciences industry.
With an international biotechnology and pharmaceuticals team of more than 80 lawyers, patent agents, and science advisers, we understand the inherent challenges of our clients' missions to develop and commercialize innovative products and services to diagnose, prevent and treat disease, and improve people's health, as well as the regulations that govern these pursuits.
Our legal team spans corporate, technology transactions, intellectual property, and litigation practices, and is dedicated to helping biotechnology and pharmaceutical companies—regardless of their size or stage—address the complex legal matters that arise during development and commercialization.
联系方式
Areas of Experience
Business Counsel to Biotechnology, Medical Device, and Pharmaceutical Clients
Perkins Coie’s business lawyers work with emerging and established biotechnology, medical device and pharmaceutical companies in the United States and abroad in a variety of areas:
- Choice of entity, corporate formation and structure, corporate governance, and public reporting
- Raising capital, including venture capital, private/preferred stock investments, debt financings, IPOs, and subsequent equity follow-on financings
- Due diligence, mergers and acquisitions
- Corporate partnering, complex licensing, strategic alliances, technology agreements, R&D collaborations, joint ventures, and supply and distribution agreements
- Business model counseling, IP strategy and the FDA approval process
- Executive compensation and equity incentive arrangements
- Real estate and land use matters
Patent Prosecution and Litigation
A significant portion of our team holds degrees in molecular biology, chemistry, or biophysics, and bring with them diverse experiences from both the life sciences industry and the U.S. Patent and Trademark Office (USPTO). We offer comprehensive services to biotechnology, medical device, and pharmaceutical enterprises in the following arenas:
- Patent portfolio management and patent procurement
- Opinions on patentability, patent infringement, validity, freedom to operate, and design-around issues
- Patent litigation to enforce rights or defend against infringement claims
- Post-grant proceedings under the America Invents Act, including inter partes review, reexaminations, and reissues
- ITC Chapter 337 actions
In addition to patent litigation, we also provide a full range of other litigation services to biotechnology and pharmaceutical companies in cases involving:
- Trademark and copyright, trade secret, and unfair competition litigation
- Product liability counseling and litigation
- Government investigations and whistleblower lawsuits
- Securities claims
- Labor and employment issues
- Contract dispute and other general business litigation matters
Industry & Technical Strengths
Our commitment to our clients has enabled us to become experts in a wide range of emergent technologies. This experience translates to the creation of high-quality patents and the development of strategic patent portfolios that align with our clients' business objectives. Our areas of practice depth include:
- AI and machine learning diagnostic tools and drug discovery and related health services
- Antibody, peptibody, and ADC therapeutics and diagnostics
- Biologics and biosimilars
- Cellular therapeutics
- Diagnostics
- Drug discovery, development, and formulation
- Gene editing including CRISPR technology
- Gene therapy including non-viral and viral gene delivery
- Genetic testing including cfDNA diagnostics and NIPT
- Genetically engineered cells and microorganisms
- Immunology including autoimmune treatment and diagnostics
- Immunotherapy including CAR-T and TCR therapy
- Microfluidics, microplates, and microarrays
- Nanotechnology
- Nucleic acid sequencing and multiplex screening
- NexGen Sequencing
- Oncology
- Peptide design and therapeutics
- Protein identification, characterization, and therapeutics
- Personalized medicine/precision medicine
- Pharmaceuticals
- Small molecule identification, synthesis, and therapeutics
- Stem cell generation, modification, and therapy
- Targeted drug delivery
- Viral diagnostics, therapeutics, and vaccines, including for COVID-19
Recognition
- U.S. News—Best Lawyers® ranked Nationally in the area of Biotechnology Law, 2013—2020
- Chambers USA for life sciences in California, 2013-2024
- Chambers Asia-Pacific as a “recognized firm” in life sciences, 2013-2015
- Ranked by Lake Whillans “Top 10 Life Sciences Law Firms” for patents, 2016-2017
